logo

Kazia Therapeutics Limited (KZIA)



Trade KZIA now with
  Date
  Headline
12/10/2020 10:02:24 AM Kazia To Collaborate With Pacific Pediatric Neuro-Oncology Consortium For Paxalisib Combination Study In DIPG
12/9/2020 10:37:38 AM Cantrixil Phase I Study Confirms Prior Positive Efficacy & Safety Signals In Persistent/recurrent Ovarian Cancer
10/16/2020 10:32:01 AM Kazia Executes Deal To Commence GBM Agile Pivotal Study
9/22/2020 10:07:23 AM Kazia Reaches Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
8/23/2020 8:55:04 PM FDA Awards Orphan Drug Designation To Paxalisib For Malignant Glioma, Including DIPG
8/20/2020 10:32:04 AM Kazia : FDA Awards Fast Track Designation To Paxalisib For Glioblastoma
8/7/2020 10:32:29 AM Kazia Therapeutics : FDA Grants Rare Pediatric Disease Designation To Paxalisib For DIPG
6/1/2020 10:31:23 AM Kazia Presents Interim Paxalisib Phase II Data At ASCO Showing Positive Overall Survival Signal
4/7/2020 8:10:26 AM Kazia's Paxalisib Shows Positive Overall Survival Signal In Phase II Glioblastoma Study
5/20/2019 8:06:48 AM Kazia Enters Clinical Collaboration For Metastatic Brain Cancer With Alliance For Clinical Trials In Oncology